2022
Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study
Stavrou E, Qiu J, Zafar A, Tramontano AC, Isakoff S, Winer E, Schrag D, Manz C. Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study. JCO Oncology Practice 2022, 18: e1447-e1453. PMID: 35671420, PMCID: PMC9509057, DOI: 10.1200/op.22.00072.Peer-Reviewed Original ResearchConceptsBreast cancer careCancer carePercent of respondentsCancer CenterDana-Farber Cancer InstituteBreast cancer followMedical oncologist's perspectiveAcademic cancer centerPatient-physician communicationUse of telemedicineMost respondentsTM visitsCancer followRoutine followOncologist's perspectiveOncology visitsPatient adherenceOncology cliniciansClinicians' perceptionsFace visitsBreast cliniciansCancer InstituteSecond opinion consultationPatient carePatient records
2011
American Society of Clinical Oncology Policy Statement: Opportunities in the Patient Protection and Affordable Care Act to Reduce Cancer Care Disparities
Moy B, Polite BN, Halpern MT, Stranne SK, Winer EP, Wollins DS, Newman LA. American Society of Clinical Oncology Policy Statement: Opportunities in the Patient Protection and Affordable Care Act to Reduce Cancer Care Disparities. Journal Of Clinical Oncology 2011, 29: 3816-3824. PMID: 21810680, DOI: 10.1200/jco.2011.35.8903.Peer-Reviewed Original ResearchConceptsCancer care disparitiesCancer careCare disparitiesAffordable Care ActCancer disparitiesClinical Oncology Policy StatementSpecific vulnerable population groupsPatient ProtectionBurden of cancerCare ActAmerican SocietyQuality of careHealth care disparitiesHealth care workforceQuality health careVulnerable population groupsVulnerable patientsClinical OncologyCareCare workforceHealth carePatientsPopulation groupsCancerHealth care law
2010
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care
Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, Keating NL. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 2010, 117: 180-189. PMID: 20939011, DOI: 10.1002/cncr.25542.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBlack PeopleBreast NeoplasmsChemotherapy, AdjuvantCombined Modality TherapyEthnicityFemaleHealthcare DisparitiesHispanic or LatinoHormonesHumansInsurance CoverageInsurance, HealthMastectomyRacial GroupsRadiotherapy, AdjuvantSocial ClassSocioeconomic FactorsWhite PeopleConceptsDefinitive locoregional therapyHormone receptor testingArea-level socioeconomic statusBreast cancer careRace/ethnicityHormonal therapyLocoregional therapyReceptor testingSocioeconomic statusCancer careHispanic womenAdjuvant hormonal therapyAdjuvant systemic therapyInvasive breast cancerBreast cancer patientsMultivariate logistic regressionBreast cancer treatmentReceipt of careEligible patientsSystemic therapyBlack raceCancer patientsInsurance statusNational cohortBreast cancerDo socioeconomic factors and insurance explain racial/ethnic disparities in receipt of recommended breast cancer care?
Freedman R, Virgo K, He Y, Pavluck A, Winer E, Ward E, Keating N. Do socioeconomic factors and insurance explain racial/ethnic disparities in receipt of recommended breast cancer care? Journal Of Clinical Oncology 2010, 28: 574-574. DOI: 10.1200/jco.2010.28.15_suppl.574.Peer-Reviewed Original Research
2007
Clinical Cancer Advances 2007: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Davidson NE, Schilsky RL, Lichter AS. Clinical Cancer Advances 2007: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology. Journal Of Clinical Oncology 2007, 26: 313-325. PMID: 18086794, DOI: 10.1200/jco.2007.15.4088.Peer-Reviewed Original ResearchConceptsNational Cancer InstituteClinical Trials Cooperative GroupsClinical OncologyCancer researchAmerican SocietyCancer treatmentScreening—A ReportHormone replacement therapyBreast cancer incidenceNumber of patientsBreast cancer screeningClinical cancer researchReplacement therapyCancer research fundingHuman papillomavirusCancer careCancer patientsCancer screeningLung cancerNeck cancerCancer incidenceClinical trialsKidney cancerLiver cancerRadiation therapyCare in the Months before Death and Hospice Enrollment Among Older Women with Advanced Breast Cancer
Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Care in the Months before Death and Hospice Enrollment Among Older Women with Advanced Breast Cancer. Journal Of General Internal Medicine 2007, 23: 11-18. PMID: 17939006, PMCID: PMC2173914, DOI: 10.1007/s11606-007-0422-y.Peer-Reviewed Original ResearchConceptsTypes of physiciansAdvanced breast cancerWeeks of deathHospice useOutpatient visitsCancer specialistsBreast cancerOlder womenStage III/IV breast cancerEnd Results-Medicare databaseAdvanced breast cancer patientsBreast cancer patientsPrimary care providersPopulation-based sampleTiming of enrollmentHospice referralPatient characteristicsHospice enrollmentHospitalized patientsCancer careCancer patientsAdjusted ratesCare providersHospitalizationPatientsCost-Effectiveness of Switching to Exemestane after 2 to 3 Years of Therapy with Tamoxifen in Postmenopausal Women with Early-Stage Breast Cancer
Thompson D, Taylor DC, Montoya EL, Winer EP, Jones SE, Weinstein MC. Cost-Effectiveness of Switching to Exemestane after 2 to 3 Years of Therapy with Tamoxifen in Postmenopausal Women with Early-Stage Breast Cancer. Value In Health 2007, 10: 367-376. PMID: 17888101, DOI: 10.1111/j.1524-4733.2007.00190.x.Peer-Reviewed Original ResearchMeSH KeywordsAgedAndrostadienesAntineoplastic ProtocolsAromatase InhibitorsBreast NeoplasmsCost-Benefit AnalysisDrug Administration ScheduleFemaleForecastingHumansMarkov ChainsMiddle AgedNeoplasm Recurrence, LocalPostmenopauseQuality-Adjusted Life YearsSEER ProgramSelective Estrogen Receptor ModulatorsTamoxifenConceptsIntergroup Exemestane StudyDisease-free survivalDisease-related eventsTreatment strategiesEarly-stage breast cancer patientsEarly-stage breast cancerProlongs disease-free survivalCost-effective treatment strategyIncremental cost-effectiveness ratioYears of tamoxifenYears of therapyBreast cancer patientsSEER-Medicare dataBreast cancer statusLifetime medical care costsMedical care costsCost-effectiveness ratioTamoxifen therapyPostmenopausal womenRecurrence rateCancer careCancer patientsPatient transitionsAromatase inhibitorsBreast cancer
2000
Involving family members in cancer care: focus group considerations of patients and oncological providers
Speice J, Harkness J, Laneri H, Frankel R, Roter D, Kornblith A, Ahles T, Winer E, Fleishman S, Luber P, Zevon M, Mcquellon R, Trief P, Finkel J, Spira J, Greenberg D, Rowland J, Holland J. Involving family members in cancer care: focus group considerations of patients and oncological providers. Psycho-Oncology 2000, 9: 101-112. PMID: 10767748, DOI: 10.1002/(sici)1099-1611(200003/04)9:2<101::aid-pon435>3.0.co;2-d.Peer-Reviewed Original Research